Polyp Size Measurement at CT Colonography: What Do We Know and What Do We Need to Know?

被引:55
|
作者
Summers, Ronald M. [1 ]
机构
[1] NIH, Imaging Biomarkers & Comp Aided Diag Lab, Dept Radiol & Imaging Sci, Ctr Clin, Bethesda, MD 20892 USA
基金
美国国家卫生研究院;
关键词
COMPUTED TOMOGRAPHIC COLONOGRAPHY; COLONIC POLYPS; COLORECTAL-CANCER; VIRTUAL COLONOSCOPY; HYPERPLASTIC POLYPS; NATURAL-HISTORY; IN-VITRO; AUTOMATED MEASUREMENT; AMERICAN-COLLEGE; NATIONAL POLYP;
D O I
10.1148/radiol.10090877
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Polyp size is a critical biomarker for clinical management. Larger polyps have a greater likelihood of being or of becoming an adenocarcinoma. To balance the referral rate for polypectomy against the risk of leaving potential cancers in situ, sizes of 6 and 10 mm are increasingly being discussed as critical thresholds for clinical decision making (immediate polypectomy versus polyp surveillance) and have been incorporated into the consensus CT Colonography Reporting and Data System (C-RADS). Polyp size measurement at optical colonoscopy, pathologic examination, and computed tomographic (CT) colonography has been studied extensively but the reported precision, accuracy, and relative sizes have been highly variable. Sizes measured at CT colonography tend to lie between those measured at optical colonoscopy and pathologic evaluation. The size measurements are subject to a variety of sources of error associated with image acquisition, display, and interpretation, such as partial volume averaging, two-versus three-dimensional displays, and observer variability. This review summarizes current best practices for polyp size measurement, describes the role of automated size measurement software, discusses how to manage the measurement uncertainties, and identifies areas requiring further research.
引用
收藏
页码:707 / 720
页数:14
相关论文
共 50 条
  • [31] Chagas Disease Chemotherapy: What Do We Know So Far?
    Zuma, Aline A.
    de Souza, Wanderley
    CURRENT PHARMACEUTICAL DESIGN, 2021, 27 (38) : 3963 - 3995
  • [32] Electronic cleansing of tagged residue in CT colonography: what radiologists need to know
    Mang, Thomas
    Braeuer, Christian
    Gryspeerdt, Stefaan
    Scharitzer, Martina
    Ringl, Helmut
    Lefere, Philippe
    INSIGHTS INTO IMAGING, 2020, 11 (01)
  • [33] Colon capsule endoscopy: What we know and what we would like to know
    Spada, Cristiano
    Barbaro, Federico
    Andrisani, Gianluca
    Grazioli, Leonardo Minelli
    Hassan, Cesare
    Costamagna, Isabella
    Campanale, Mariachiara
    Costamagna, Guido
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (45) : 16948 - 16955
  • [34] Optimizing dosing of nitrofurantoin from a PK/PD point of view: What do we need to know?
    Wijma, Rixt A.
    Fransen, Fiona
    Muller, Anouk E.
    Mouton, Johan W.
    DRUG RESISTANCE UPDATES, 2019, 43 : 1 - 9
  • [35] What do we actually know about exosomal microRNAs in kidney diseases?
    Li, Qianyu
    Zhang, Zhiping
    Yin, Min
    Cui, Cancan
    Zhang, Yucheng
    Wang, Yali
    Liu, Feng
    FRONTIERS IN PHYSIOLOGY, 2022, 13
  • [36] Enterotoxigenic Escherichia coli and probiotics in swine: what the bleep do we know?
    Dubreuil, Jean Daniel
    BIOSCIENCE OF MICROBIOTA FOOD AND HEALTH, 2017, 36 (03): : 75 - 90
  • [37] Leg Length Discrepancy: The Natural History (And What Do We Really Know)
    Gordon, J. Eric
    Davis, Lauren E.
    JOURNAL OF PEDIATRIC ORTHOPAEDICS, 2019, 39 (06) : S10 - S13
  • [38] What Do We (Not) Know About Antibiotic-loaded Hip Spacers?
    Anagnostakos, Konstantinos
    ORTHOPEDICS, 2014, 37 (05) : 297 - 298
  • [39] Genetic testing in adults with developmental and epileptic encephalopathy - what do we know?
    Krey, Ilona
    Johannesen, Kathrine M.
    Kohnen, Oona
    Lemke, Johannes R.
    MEDIZINISCHE GENETIK, 2022, 34 (03) : 207 - 213
  • [40] What Do We Really Know about Cellulose Biosynthesis in Higher Plants?
    Guerriero, Gea
    Fugelstad, Johanna
    Bulone, Vincent
    JOURNAL OF INTEGRATIVE PLANT BIOLOGY, 2010, 52 (02) : 161 - 175